These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 17556170

  • 1. Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: a positron emission tomography study.
    Tuunanen H, Kuusisto J, Toikka J, Jääskeläinen P, Marjamäki P, Peuhkurinen K, Viljanen T, Sipola P, Stolen KQ, Hannukainen J, Nuutila P, Laakso M, Knuuti J.
    J Nucl Cardiol; 2007; 14(3):354-65. PubMed ID: 17556170
    [Abstract] [Full Text] [Related]

  • 2. Cine MR imaging of myocardial contractile impairment in patients with hypertrophic cardiomyopathy attributable to Asp175Asn mutation in the alpha-tropomyosin gene.
    Sipola P, Lauerma K, Jääskeläinen P, Laakso M, Peuhkurinen K, Manninen H, Aronen HJ, Kuusisto J.
    Radiology; 2005 Sep; 236(3):815-24. PubMed ID: 16014439
    [Abstract] [Full Text] [Related]

  • 3. First-pass MR imaging in the assessment of perfusion impairment in patients with hypertrophic cardiomyopathy and the Asp175Asn mutation of the alpha-tropomyosin gene.
    Sipola P, Lauerma K, Husso-Saastamoinen M, Kuikka JT, Vanninen E, Laitinen T, Manninen H, Niemi P, Peuhkurinen K, Jääskeläinen P, Laakso M, Kuusisto J, Aronen HJ.
    Radiology; 2003 Jan; 226(1):129-37. PubMed ID: 12511681
    [Abstract] [Full Text] [Related]

  • 4. Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction.
    Tuunanen H, Engblom E, Naum A, Scheinin M, Någren K, Airaksinen J, Nuutila P, Iozzo P, Ukkonen H, Knuuti J.
    J Card Fail; 2006 Oct; 12(8):644-52. PubMed ID: 17045185
    [Abstract] [Full Text] [Related]

  • 5. Image-guided cardiovascular functional genomics: finding the needle in the haystack.
    Cresci S, Gropler RJ.
    J Nucl Cardiol; 2007 Oct; 14(3):275-6. PubMed ID: 17556159
    [No Abstract] [Full Text] [Related]

  • 6. Inducibility of life-threatening ventricular arrhythmias is related to maximum left ventricular thickness and clinical markers of sudden cardiac death in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
    Hedman A, Hartikainen J, Vanninen E, Laitinen T, Jääskeläinen P, Laakso M, Peuhkurinen K, Kuusisto J.
    J Mol Cell Cardiol; 2004 Jan; 36(1):91-9. PubMed ID: 14734051
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid.
    Turpeinen AK, Takala TO, Nuutila P, Axelin T, Luotolahti M, Haaparanta M, Bergman J, Hämäläinen H, Iida H, Mäki M, Uusitupa MI, Knuuti J.
    Diabetes; 1999 Jun; 48(6):1245-50. PubMed ID: 10342811
    [Abstract] [Full Text] [Related]

  • 9. Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction.
    Timmer SA, Germans T, Brouwer WP, Lubberink M, van der Velden J, Wilde AA, Christiaans I, Lammertsma AA, Knaapen P, van Rossum AC.
    Eur J Heart Fail; 2011 Dec; 13(12):1283-9. PubMed ID: 22021246
    [Abstract] [Full Text] [Related]

  • 10. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid].
    Kobayashi H, Nakata T, Han S, Takahashi N, Hashimoto A, Tsuchihashi K, Nagao K, Tanaka S, Shimamoto K, Iimura O.
    J Cardiol; 1994 Dec; 24(1):35-43. PubMed ID: 8158529
    [Abstract] [Full Text] [Related]

  • 11. Cardiac adrenergic activity is associated with left ventricular hypertrophy in genetically homogeneous subjects with hypertrophic cardiomyopathy.
    Sipola P, Vanninen E, Aronen HJ, Lauerma K, Simula S, Jääskeläinen P, Laakso M, Peuhkurinen K, Kuusisto J, Kuikka JT.
    J Nucl Med; 2003 Apr; 44(4):487-93. PubMed ID: 12679389
    [Abstract] [Full Text] [Related]

  • 12. 14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid as a tracer of free fatty acid uptake and oxidation in myocardium and skeletal muscle.
    Takala TO, Nuutila P, Pulkki K, Oikonen V, Grönroos T, Savunen T, Vähäsilta T, Luotolahti M, Kallajoki M, Bergman J, Forsback S, Knuuti J.
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1617-22. PubMed ID: 12458396
    [Abstract] [Full Text] [Related]

  • 13. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA, Rowin EJ, Maron MS, Crean A, Pandian NG.
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
    Magga J, Sipola P, Vuolteenaho O, Risteli J, Jääskeläinen P, Peuhkurinen K, Kuusisto J.
    Am J Cardiol; 2008 Apr 15; 101(8):1185-90. PubMed ID: 18394456
    [Abstract] [Full Text] [Related]

  • 18. Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the alpha-tropomyosin gene.
    Coviello DA, Maron BJ, Spirito P, Watkins H, Vosberg HP, Thierfelder L, Schoen FJ, Seidman JG, Seidman CE.
    J Am Coll Cardiol; 1997 Mar 01; 29(3):635-40. PubMed ID: 9060904
    [Abstract] [Full Text] [Related]

  • 19. Impact of Global and Segmental Hypertrophy on Two-Dimensional Strain Derived from Three-Dimensional Echocardiography in Hypertrophic Cardiomyopathy: Comparison with Healthy Subjects.
    Voilliot D, Huttin O, Hammache N, Filippetti L, Vaugrenard T, Aliot E, Sadoul N, Juillière Y, Selton-Suty C.
    J Am Soc Echocardiogr; 2015 Sep 01; 28(9):1093-102. PubMed ID: 25935111
    [Abstract] [Full Text] [Related]

  • 20. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy.
    Tadamura E, Kudoh T, Hattori N, Inubushi M, Magata Y, Konishi J, Matsumori A, Nohara R, Sasayama S, Yoshibayashi M, Tamaki N.
    J Nucl Med; 1998 Mar 01; 39(3):390-6. PubMed ID: 9529280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.